Patent US4528288A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4528288A Expired / Lapsed US ⏱️ 0.0 years remaining

Substituted triazolo[1,5-c]pyrimidines

Assignee: Riker Laboratories Inc
•
Filing: 1983-05-02
•
Granted: 1985-07-09
•
Expires: 2003-05-02
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Substituted triazolo[1,5-c]pyrimidines which are bronchodilators. The pharmacological use of these compounds and pharmaceutical compositions containing these compounds are also described.

Inventors

  • 👤 James J. Wade

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-08 17:16
CPC Classifications
C; C07; C07D; C07D487/00; C07D487/02; C07D487/04; C07D239/00; C07D239/02; C07D239/24; C07D239/28; C07D239/46; C07D239/58

Claims Analysis

Total Claims: 12
Claim 1
Independent Claim 37 words
A compound of the formula: ##STR6## wherein R 2 is hydrogen or lower alkyl; R 5 is benzylthio; and R 7 and R 8 are independently hydrogen or lower alkyl; or a pharmaceutically acceptable acid-addition salt thereof.
Claim 2
Dependent Claim 37 words
A compound of the formula: ##STR6## wherein R 2 is hydrogen or lower alkyl; R 5 is benzylthio; and R 7 and R 8 are independently hydrogen or lower alkyl; or a pharmaceutically acceptable acid-addition salt thereof.
Claim 3
Dependent Claim 48 words
A compound of the formula: ##STR7## wherein R 2 is mercapto, lower alkoxy, lower alkylthio or hydroxy; R 5 is lower alkylthio; R 7 is hydrogen, lower alkyl, lower alkylthio or halogen; and R 8 is hydrogen, lower alkyl, or halogen; or a pharmaceutically acceptable acid-addition salt thereof.
Claim 4
Dependent Claim 48 words
A compound of the formula: ##STR7## wherein R 2 is mercapto, lower alkoxy, lower alkylthio or hydroxy; R 5 is lower alkylthio; R 7 is hydrogen, lower alkyl, lower alkylthio or halogen; and R 8 is hydrogen, lower alkyl, or halogen; or a pharmaceutically acceptable acid-addition salt thereof.
Claim 5
Dependent Claim 41 words
A compound of the formula: ##STR8## wherein R 2 is hydroxy; R 5 is lower alkylthio; R 7 is hydrogen, lower alkyl, lower alkylthio, or halogen; and R 8 is hydrogen or lower alkyl; or a pharmaceutically acceptable acid-addition salt thereof.
Claim 6
Dependent Claim 41 words
A compound of the formula: ##STR8## wherein R 2 is hydroxy; R 5 is lower alkylthio; R 7 is hydrogen, lower alkyl, lower alkylthio, or halogen; and R 8 is hydrogen or lower alkyl; or a pharmaceutically acceptable acid-addition salt thereof.
Claim 7
Dependent Claim 20 words
A bronchodilator pharmaceutical composition comprising an effective amount of a compound according to claim 1 and a pharmaceutically acceptable carrier.
Claim 8
Dependent Claim 20 words
A bronchodilator pharmaceutical composition comprising an effective amount of a compound according to claim 2 and a pharmaceutically acceptable carrier.
Claim 9
Dependent Claim 20 words
A bronchodilator pharmaceutical composition comprising an effective amount of a compound according to claim 3 and a pharmaceutically acceptable carrier.
Claim 10
Independent Claim 144 words
A method for obtaining bronchodilation in a mammal, wherein an effective amount of a bronchodilator compound is administered to said mammal, said bronchodilator compound being of the formula ##STR9## wherein R 2 is hydrogen, lower alkyl, mercapto, lower alkylthio, lower alkoxy or hydroxy; R 5 is (lower alkyl)amino, di(lower alkyl)amino, alklthio or benzylthio; R 7 is hydrogen, lower alkyl, halogen or lower alkylthio; and R 8 is hydrogen, lower alkyl or halogen, and is hydrogen or lower alkyl when R 7 is halogen; with the provisos that at least one of R 5 and R 7 is lower alkylthio, (lower alkyl)amino, di(lower alkyl)amino, or benzylthio; and when one of R 5 and R 7 is lower alkylthio, at least another one of R 2 , R 5 and R 7 is mercapto, lower alkylthio or lower alkoxy; or a pharmaceutically acceptable acid-addition salt thereof.
Claim 11
Independent Claim 144 words
A method for obtaining bronchodilation in a mammal, wherein an effective amount of a bronchodilator compound is administered to said mammal, said bronchodilator compound being of the formula ##STR9## wherein R 2 is hydrogen, lower alkyl, mercapto, lower alkylthio, lower alkoxy or hydroxy; R 5 is (lower alkyl)amino, di(lower alkyl)amino, alklthio or benzylthio; R 7 is hydrogen, lower alkyl, halogen or lower alkylthio; and R 8 is hydrogen, lower alkyl or halogen, and is hydrogen or lower alkyl when R 7 is halogen; with the provisos that at least one of R 5 and R 7 is lower alkylthio, (lower alkyl)amino, di(lower alkyl)amino, or benzylthio; and when one of R 5 and R 7 is lower alkylthio, at least another one of R 2 , R 5 and R 7 is mercapto, lower alkylthio or lower alkoxy; or a pharmaceutically acceptable acid-addition salt thereof.
Claim 12
Dependent Claim 12 words
A method according to claim 7, wherein said compound is administered orally.

References Cited (Backward Citations)

DE1074589B Cited
FR1205144A Cited
GB859287A Cited
US3045015A Cited
GB873223A Cited
US3053844A Cited
GB897870A Cited
US3046276A Cited
GB898409A Cited
US3689488A Cited
DE3029871A1 Cited
US4269980A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1988-07-08 1989-01-07 1989-07-09 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1992-07-08 1993-01-07 1993-07-09 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1996-07-08 1997-01-07 1997-07-09 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag